» Authors » Ann N Burchell

Ann N Burchell

Explore the profile of Ann N Burchell including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 175
Citations 2894
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chawla S, Kaida A, Brouillette M, Kleiner B, Dubuc D, Skerritt L, et al.
HIV Med . 2025 Mar; PMID: 40040329
Background: While the negative effects of mental health issues on HIV clinical outcomes have been well-documented, the impact of mental health treatment on the HIV care cascade is largely uncharacterized....
2.
McGarrity M, Lisk R, MacPherson P, Knox D, Woodward K, Reinhart J, et al.
Open Forum Infect Dis . 2025 Jan; 12(1):ofaf014. PMID: 39877400
Background: Hepatitis C virus (HCV) has emerged as a sexually transmitted infection in gay, bisexual, and other men who have sex with men (GBM). We estimated the seroprevalence and incidence...
3.
Ng K, El-Zein M, Wissing M, Burchell A, Tellier P, Coutlee F, et al.
J Med Virol . 2025 Jan; 97(1):e70163. PMID: 39812113
The protective effect of naturally acquired humoral immunity against human papillomavirus (HPV) infection remains unclear. To investigate the role of infection-induced antibodies on HPV detection in heterosexual partners, we used...
4.
Lu J, Vulesevic B, Burchell A, Singer J, Needham J, Yang Y, et al.
Vaccine X . 2024 Nov; 21:100566. PMID: 39582795
Background: Understanding the roots of vaccine confidence in vulnerable populations, such as persons living with HIV (PLWH), is important to facilitate vaccine uptake, thus mitigating infection and spread of vaccine-preventable...
5.
Chambers C, Cooper C, Kroch A, Buchan S, Kendall C, Kwong J, et al.
AIDS . 2024 Oct; 38(10):1597-1600. PMID: 39422634
We found that rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and reverse transcriptase (RT)-PCR-confirmed infection were approximately 50% higher in a population-based cohort of people with HIV...
6.
Rudd M, McGarrity M, Lisk R, MacPherson P, Knox D, Woodward K, et al.
AIDS Patient Care STDS . 2024 Sep; 38(9):382-392. PMID: 39284166
Side effects are a common concern of current and potential HIV pre-exposure prophylaxis (PrEP) users, potentially leading to missed doses. We examined the relationship between reported side effects and adherence...
7.
Navarro C, Lau C, Buchan S, Burchell A, Nasreen S, Friedman L, et al.
BMJ . 2024 Sep; 386:e078243. PMID: 39260880
Objective: To estimate the real world effectiveness of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine against mpox infection. Design: Emulation of a target trial. Setting: Linked databases in Ontario, Canada. Participants:...
8.
Chawla S, Kaida A, Brouillette M, Kleiner B, Dubuc D, Skerritt L, et al.
BMC Health Serv Res . 2024 Aug; 24(1):923. PMID: 39135046
Background: The prevalence of mental health conditions among women with HIV in Canada ranges between 29.5% and 57.4%, highlighting the need for accessible mental health care. We aimed to (1)...
9.
Alessandrini J, Cox J, de Pokomandy A, Hart T, Grace D, Grennan T, et al.
J Infect Dis . 2024 Jul; 230(5):e1039-e1048. PMID: 39041706
Background: Oral human papillomavirus (HPV) infections are a leading cause of oropharyngeal cancers. In 2015 and 2016, HPV vaccines became publicly funded for gay, bisexual, and other men who have...
10.
Nicolau I, Moineddin R, Brooks J, Antoniou T, Gillis J, Kendall C, et al.
J Acquir Immune Defic Syndr . 2024 Jul; 96(5):447-456. PMID: 38985442
Background: People with HIV are at higher risk of infection-related cancers than the general population, which could be due, in part, to immune dysfunction. Our objective was to examine associations...